Skip to main content

Épidémiologie et diversité des cancers du sein N Étude sur une cohorte de plus de 5 000 patientes traitées au Centre Antoine Lacassagne (Nice, France)

  • Conference paper
Cancer du sein

Résumé

Dans le cancer du sein, de nombreux facteurs pronostiques et prédictifs sont accessibles, ces facteurs permettent d’évaluer l’évolution de la maladie mais aussi d’affiner le choix d’une prise en charge thérapeutique. Le statut d’envahissement ganglionnaire (positif ou atients) est un des plus importants paramètres pronostiques indépendants [1]. Les patientes montrant un envahissement ganglionnaire négatif présentent une maladie à bas ou moyen risque alors que les malades montrant au moins un ganglion envahi sont d’emblée considérées à moyen ou haut risque [2]. Le statut ganglionnaire doit être considéré comme un facteur pronostique » pur « et non comme un facteur prédictif permettant de prédire la réponse au traitement

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Mamounas EP (2009) Age and l 1. ymph node status in breast cancer: not a straightforward relationship. J Clin Oncol 27: 2900–2901

    Article  PubMed  Google Scholar 

  2. Goldhirsch A, Glick JH, Gelber RD et al. (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16: 1569–1583

    Article  PubMed  CAS  Google Scholar 

  3. Lonning PE (2007) Breast cancer prognostication and prediction: are we making progress? Ann Oncol 18: viii3–viii7

    Article  PubMed  Google Scholar 

  4. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365: 1687–1717

    Article  Google Scholar 

  5. Lonning PE, Knappskog S, Staalesen V et al. (2007) Breast cancer prognostication and prediction in the postgenomic era. Ann Oncol 18: 1293–1306

    Article  PubMed  CAS  Google Scholar 

  6. Singletary SE, Allred C, Ashley P et al. (2002) Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20: 3628–3636

    Article  PubMed  Google Scholar 

  7. Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359–377

    Article  PubMed  CAS  Google Scholar 

  8. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with longterm follow-up. Histopathology 19: 403–410

    Article  PubMed  CAS  Google Scholar 

  9. Milano G, Moll JL, Formento JL et al. (1983) Simultaneous micro measurement of steroid receptors in breast cancer. Br J Cancer 48: 579–584

    Article  PubMed  CAS  Google Scholar 

  10. Romain S, Formento JL, Guirou O et al. (1994) Determination of oestrogen receptors by enzyme immunoassay. Technical differences between laboratories and their consequences. Eur J Cancer 30A: 740–746

    Article  PubMed  CAS  Google Scholar 

  11. Blankenstein MA (1990) Comparison of ligand binding assay and enzyme immunoassay of oestrogen receptor in human breast cancer cytosols. Experience of the E.O.R.T.C. Receptor Group. Breast Cancer Res Treat 17: 91–98

    Article  PubMed  CAS  Google Scholar 

  12. Blancas I, Gomez FJ, Bermejo B et al. (2009) Outcome differences between patients with node-negative breast cancer classified according to the st. Gallen risk categories. Clin Breast Cancer 9: 231–236

    Article  PubMed  Google Scholar 

  13. Look MP, van Putten WL, Duffy MJ et al. (2002) Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J Natl Cancer Inst 94: 116–128

    Article  PubMed  CAS  Google Scholar 

  14. Truong PT, Yong CM, Abnousi F et al. (2005) Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy. J Am Coll Surg 200: 912–921

    Article  PubMed  Google Scholar 

  15. Truong PT, Lesperance M, Li KH et al. (2010) Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series. Ann Surg Oncol 17: 2138–2146

    Article  PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag France, Paris

About this paper

Cite this paper

Chamorey, E. et al. (2012). Épidémiologie et diversité des cancers du sein N Étude sur une cohorte de plus de 5 000 patientes traitées au Centre Antoine Lacassagne (Nice, France). In: Cancer du sein. Springer, Paris. https://doi.org/10.1007/978-2-8178-0245-9_28

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0245-9_28

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0244-2

  • Online ISBN: 978-2-8178-0245-9

Publish with us

Policies and ethics